Evidence map›Paper›PMID 40317577›Full record

ArticleMedical physics2025

Modeling inter-reader variability in clinical target volume delineation for soft tissue sarcomas using diffusion model.

Yafei Dong, Thibault Marin, Yue Zhuo, Elie Najem, Arnaud Beddok, Laura Rozenblum, Maryam Moteabbed, Kira Grogg, Fangxu Xing, Jonghye Woo and 5 more

Abstract read
In one paragraph

Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yafei DongYale Biomedical Imaging Institute, Yale University School of Medicine, New Haven, Connecticut, USA.
Thibault MarinYale Biomedical Imaging Institute, Yale University School of Medicine, New Haven, Connecticut, USA.
Yue ZhuoYale Biomedical Imaging Institute, Yale University School of Medicine, New Haven, Connecticut, USA.
Elie NajemDepartment of Imaging, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Arnaud BeddokYale Biomedical Imaging Institute, Yale University School of Medicine, New Haven, Connecticut, USA.
Laura RozenblumYale Biomedical Imaging Institute, Yale University School of Medicine, New Haven, Connecticut, USA.
Maryam MoteabbedDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Kira GroggYale Biomedical Imaging Institute, Yale University School of Medicine, New Haven, Connecticut, USA.
Fangxu XingGordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Jonghye WooGordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Yen-Lin E ChenDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Ruth LimYale Biomedical Imaging Institute, Yale University School of Medicine, New Haven, Connecticut, USA.
Xiaofeng LiuYale Biomedical Imaging Institute, Yale University School of Medicine, New Haven, Connecticut, USA.
Chao MaYale Biomedical Imaging Institute, Yale University School of Medicine, New Haven, Connecticut, USA.
Georges El FakhriYale Biomedical Imaging Institute, Yale University School of Medicine, New Haven, Connecticut, USA.

Funding

Unified Joint Statistical Reconstruction of PET & MRP41EB022544 · NIBIB · YALE UNIVERSITY · PI Georges El Fakhri · 2017 to 2026
$14.8M
Quantitative Oncologic PET-MRR01CA165221 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI EL FAKHRI, GEORGES · 2012 to 2023
$4.7M
Improving Image-Guided Radiation Therapy of Gliomas with High-Resolution MR Spectroscopic ImagingR01EB033582 · NIBIB · YALE UNIVERSITY · PI Chao Ma · 2022 to 2026
$2.0M
Deep learning-based target volume delineation capturing observer variability in head and neck cancerR01CA290745 · NCI · YALE UNIVERSITY · PI Georges El Fakhri · 2024 to 2026
$1.7M
Improved drug efficacy assessment using joint Bayesian estimation frameworkR01EB035093 · NIBIB · YALE UNIVERSITY · PI Thibault Marin · 2024 to 2026
$1.2M
Deep Learning for Individualized Treatment Effect Inference with Multimodal DepictionR21EB034911 · NIBIB · YALE UNIVERSITY · PI Xiaofeng Liu · 2024 to 2026
$653k
NCI NIH HHS R01 CA165221NCI NIH HHS R01CA165221NCI NIH HHS R01 CA290745NCI NIH HHS R01CA290745NIBIB NIH HHS P41 EB022544NIBIB NIH HHS P41EB022544NIBIB NIH HHS R01 EB033582NIBIB NIH HHS R01EB033582NIBIB NIH HHS R01 EB035093NIBIB NIH HHS R01EB035093NIBIB NIH HHS R21 EB034911NIBIB NIH HHS R21EB034911U.S. Department of Energy DE-AC05-00OR22725
6 · The paper itself

Abstract

backgroundAccurate delineation of the clinical target volume (CTV) is essential in the radiotherapy treatment of soft tissue sarcomas. However, this process is subject to inter-reader variability due to the need for clinical assessment of risk and extent of potential microscopic spread. This can lead to inconsistencies in treatment planning, potentially impacting treatment outcomes. Most existing automatic CTV delineation methods do not account for this variability and can only generate a single CTV for each case. PURPOSE: This study aims to develop a deep learning-based technique to generate multiple CTV contours for each case, simulating the inter-reader variability in the clinical practice.

methodsWe employed a publicly available dataset consisting of fluorodeoxyglucose positron emission tomography (FDG-PET), x-ray computed tomography (CT), and pre-contrast T1-weighted magnetic resonance imaging (MRI) scans from 51 patients with soft tissue sarcoma, along with an independent validation set containing five additional patients. An experienced reader drew a contour of the gross tumor volume (GTV) for each patient based on multi-modality images. Subsequently, two additional readers, together with the first one, were responsible for contouring three CTVs in total based on the GTV. We developed a diffusion model-based deep learning method that is capable of generating arbitrary number of different and plausible CTVs to mimic the inter-reader variability in CTV delineation. The proposed model incorporates a separate encoder to extract features from the GTV masks, leveraging the critical role of GTV information in accurate CTV delineation.

resultsThe proposed diffusion model demonstrated superior performance with the highest Dice Index (0.902 compared to values below 0.881 for state-of-the-art models) and the best generalized energy distance (GED) (0.209 compared to values exceeding 0.221 for state-of-the-art models). It also achieved the second-highest recall and precision metrics among the compared ambiguous image segmentation models. Results from both datasets exhibited consistent trends, reinforcing the reliability of our findings. Additionally, ablation studies exploring different model structures and input configurations highlighted the significance of incorporating prior GTV information for accurate CTV delineation.

conclusionsThe proposed diffusion model successfully generates multiple plausible CTV contours for soft tissue sarcomas, effectively capturing inter-reader variability in CTV delineation.

Indexed as

Image Processing, Computer-AssistedSarcomaSoft Tissue NeoplasmsDeep LearningDiffusionHumansObserver VariationTomography, X-Ray ComputedTumor Burdenclinical target volumedeep learningdiffusion modelgross tumor volumesarcoma

Identifiers

PMID40317577
PMCPMC12424543

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.